ID   ST17A_HUMAN             Reviewed;         414 AA.
AC   Q9UEE5; A4D1V6; Q8IVC8;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   15-MAR-2017, entry version 153.
DE   RecName: Full=Serine/threonine-protein kinase 17A;
DE            EC=2.7.11.1;
DE   AltName: Full=DAP kinase-related apoptosis-inducing protein kinase 1;
GN   Name=STK17A; Synonyms=DRAK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   AUTOPHOSPHORYLATION, TISSUE SPECIFICITY, MUTAGENESIS OF LYS-90, AND
RP   VARIANT GLU-362.
RC   TISSUE=Liver, and Placenta;
RX   PubMed=9786912; DOI=10.1074/jbc.273.44.29066;
RA   Sanjo H., Kawai T., Akira S.;
RT   "DRAKs, novel serine/threonine kinases related to death-associated
RT   protein kinase that trigger apoptosis.";
RL   J. Biol. Chem. 273:29066-29071(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-362.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-362.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-362.
RC   TISSUE=Colon, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INDUCTION.
RX   PubMed=15940259; DOI=10.1038/sj.onc.1208755;
RA   Kerley-Hamilton J.S., Pike A.M., Li N., DiRenzo J., Spinella M.J.;
RT   "A p53-dominant transcriptional response to cisplatin in testicular
RT   germ cell tumor-derived human embryonal carcinoma.";
RL   Oncogene 24:6090-6100(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=21802008; DOI=10.1016/j.chembiol.2011.05.010;
RA   Miduturu C.V., Deng X., Kwiatkowski N., Yang W., Brault L.,
RA   Filippakopoulos P., Chung E., Yang Q., Schwaller J., Knapp S.,
RA   King R.W., Lee J.D., Herrgard S., Zarrinkar P., Gray N.S.;
RT   "High-throughput kinase profiling: a more efficient approach toward
RT   the discovery of new kinase inhibitors.";
RL   Chem. Biol. 18:868-879(2011).
RN   [10]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=21489989; DOI=10.1074/jbc.M111.218040;
RA   Mao P., Hever M.P., Niemaszyk L.M., Haghkerdar J.M., Yanco E.G.,
RA   Desai D., Beyrouthy M.J., Kerley-Hamilton J.S., Freemantle S.J.,
RA   Spinella M.J.;
RT   "Serine/threonine kinase 17A is a novel p53 target gene and modulator
RT   of cisplatin toxicity and reactive oxygen species in testicular cancer
RT   cells.";
RL   J. Biol. Chem. 286:19381-19391(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND SER-28, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-126; THR-167; GLN-286 AND GLU-362.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts as a positive regulator of apoptosis. Also acts as
CC       a regulator of cellular reactive oxygen species.
CC       {ECO:0000269|PubMed:21489989, ECO:0000269|PubMed:9786912}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Inhibited by thiazolidinedione-type compounds:
CC       inhibited by furan- and pyridone- thiazolidinediones.
CC       {ECO:0000269|PubMed:21802008}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9786912}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta. Lower levels in
CC       heart, lung, skeletal muscle, kidney and pancreas.
CC       {ECO:0000269|PubMed:9786912}.
CC   -!- INDUCTION: Directly regulated by p53/TP53: induced following
CC       cisplatin treatment in a p53/TP53-dependent manner. p53/TP53
CC       activates expression by directly binding to its regulatory
CC       regions. {ECO:0000269|PubMed:15940259,
CC       ECO:0000269|PubMed:21489989}.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. DAP kinase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB011420; BAA34126.1; -; mRNA.
DR   EMBL; CH236951; EAL24008.1; -; Genomic_DNA.
DR   EMBL; AC005189; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011738; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093645; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW94162.1; -; Genomic_DNA.
DR   EMBL; BC023508; AAH23508.2; -; mRNA.
DR   EMBL; BC047696; AAH47696.1; -; mRNA.
DR   CCDS; CCDS5470.1; -.
DR   RefSeq; NP_004751.2; NM_004760.2.
DR   UniGene; Hs.709489; -.
DR   ProteinModelPortal; Q9UEE5; -.
DR   SMR; Q9UEE5; -.
DR   BioGrid; 114685; 1.
DR   IntAct; Q9UEE5; 4.
DR   STRING; 9606.ENSP00000319192; -.
DR   BindingDB; Q9UEE5; -.
DR   ChEMBL; CHEMBL4525; -.
DR   GuidetoPHARMACOLOGY; 2214; -.
DR   iPTMnet; Q9UEE5; -.
DR   PhosphoSitePlus; Q9UEE5; -.
DR   BioMuta; STK17A; -.
DR   DMDM; 317373279; -.
DR   EPD; Q9UEE5; -.
DR   MaxQB; Q9UEE5; -.
DR   PaxDb; Q9UEE5; -.
DR   PeptideAtlas; Q9UEE5; -.
DR   PRIDE; Q9UEE5; -.
DR   DNASU; 9263; -.
DR   Ensembl; ENST00000319357; ENSP00000319192; ENSG00000164543.
DR   GeneID; 9263; -.
DR   KEGG; hsa:9263; -.
DR   UCSC; uc003tih.4; human.
DR   CTD; 9263; -.
DR   DisGeNET; 9263; -.
DR   GeneCards; STK17A; -.
DR   H-InvDB; HIX0019195; -.
DR   H-InvDB; HIX0025491; -.
DR   HGNC; HGNC:11395; STK17A.
DR   HPA; HPA018138; -.
DR   HPA; HPA037979; -.
DR   MIM; 604726; gene.
DR   neXtProt; NX_Q9UEE5; -.
DR   OpenTargets; ENSG00000164543; -.
DR   PharmGKB; PA36203; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00760000118877; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG106718; -.
DR   InParanoid; Q9UEE5; -.
DR   KO; K08804; -.
DR   OMA; YSLCPGR; -.
DR   OrthoDB; EOG091G0J2O; -.
DR   PhylomeDB; Q9UEE5; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; Q9UEE5; -.
DR   SIGNOR; Q9UEE5; -.
DR   ChiTaRS; STK17A; human.
DR   GenomeRNAi; 9263; -.
DR   PRO; PR:Q9UEE5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164543; -.
DR   CleanEx; HS_STK17A; -.
DR   Genevisible; Q9UEE5; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    414       Serine/threonine-protein kinase 17A.
FT                                /FTId=PRO_0000086704.
FT   DOMAIN       61    321       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      67     75       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS     33     37       Poly-Pro.
FT   ACT_SITE    186    186       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      90     90       ATP.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      28     28       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     126    126       E -> D (in dbSNP:rs56286238).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041145.
FT   VARIANT     167    167       M -> T (in dbSNP:rs35940029).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041146.
FT   VARIANT     286    286       E -> Q (in dbSNP:rs3779062).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_032823.
FT   VARIANT     362    362       K -> E (in dbSNP:rs1044141).
FT                                {ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:9786912,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019991.
FT   MUTAGEN      90     90       K->A: Loss of activity and of apoptotic
FT                                function. {ECO:0000269|PubMed:9786912}.
SQ   SEQUENCE   414 AA;  46558 MW;  E2140290492C2A10 CRC64;
     MIPLEKPGSG GSSPGATSGS GRAGRGLSGP CRPPPPPQAR GLLTEIRAVV RTEPFQDGYS
     LCPGRELGRG KFAVVRKCIK KDSGKEFAAK FMRKRRKGQD CRMEIIHEIA VLELAQDNPW
     VINLHEVYET ASEMILVLEY AAGGEIFDQC VADREEAFKE KDVQRLMRQI LEGVHFLHTR
     DVVHLDLKPQ NILLTSESPL GDIKIVDFGL SRILKNSEEL REIMGTPEYV APEILSYDPI
     SMATDMWSIG VLTYVMLTGI SPFLGNDKQE TFLNISQMNL SYSEEEFDVL SESAVDFIRT
     LLVKKPEDRA TAEECLKHPW LTQSSIQEPS FRMEKALEEA NALQEGHSVP EINSDTDKSE
     TKESIVTEEL IVVTSYTLGQ CRQSEKEKME QKAISKRFKF EEPLLQEIPG EFIY
//
